These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9166934)

  • 1. In vivo (31)P magnetic resonance spectroscopy and morphometric analysis of the perfused vascular architecture of human glioma xenografts in nude mice.
    van der Sanden BP; Rijken PF; Heerschap A; Bernsen HJ; van der Kogel AJ
    Br J Cancer; 1997; 75(10):1432-8. PubMed ID: 9166934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global HDO uptake in human glioma xenografts is related to the perfused capillary distribution.
    van der Sanden BP; in't Zandt HJ; Hoofd L; de Graaf RA; Nicolay K; Rijken PF; van der Kogel AJ; Heerschap A
    Magn Reson Med; 1999 Sep; 42(3):479-89. PubMed ID: 10467292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascularity and perfusion of human gliomas xenografted in the athymic nude mouse.
    Bernsen HJ; Rijken PF; Oostendorp T; van der Kogel AJ
    Br J Cancer; 1995 Apr; 71(4):721-6. PubMed ID: 7710935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 31P-nuclear magnetic resonance spectroscopy in vivo of six human melanoma xenograft lines: tumour bioenergetic status and blood supply.
    Lyng H; Olsen DR; Southon TE; Rofstad EK
    Br J Cancer; 1993 Dec; 68(6):1061-70. PubMed ID: 8260356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suramin treatment of human glioma xenografts; effects on tumor vasculature and oxygenation status.
    Bernsen HJ; Rijken PF; Peters JP; Bakker JH; Boerman RH; Wesseling P; van der Kogel AJ
    J Neurooncol; 1999 Sep; 44(2):129-36. PubMed ID: 10619496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Establishment and characterization of dual-color fluorescence nude mouse models of glioma].
    Zhang J; Lu Z; Fei X; Dai X; Wu J; Wan Y; Wang Z; Wang A; Dong J; Lan Q; Huang Q
    Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):97-102. PubMed ID: 24796456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of an image analysis system to the quantitation of tumor perfusion and vascularity in human glioma xenografts.
    Rijken PF; Bernsen HJ; van der Kogel AJ
    Microvasc Res; 1995 Sep; 50(2):141-53. PubMed ID: 8538495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A quantitative analysis of vascularization and perfusion of human glioma xenografts at different implantation sites.
    Bernsen HJ; Rijken PF; Hagemeier NE; van der Kogel AJ
    Microvasc Res; 1999 May; 57(3):244-57. PubMed ID: 10329251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spatial relationship between hypoxia and the (perfused) vascular network in a human glioma xenograft: a quantitative multi-parameter analysis.
    Rijken PF; Bernsen HJ; Peters JP; Hodgkiss RJ; Raleigh JA; van der Kogel AJ
    Int J Radiat Oncol Biol Phys; 2000 Sep; 48(2):571-82. PubMed ID: 10974478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of glucose and confluency on phosphorus metabolites of perfused human prostatic adenocarcinoma cells as determined by 31P MRS.
    Macdonald JM; Kurhanewicz J; Dahiya R; Espanol MT; Chang LH; Goldberg B; James TL; Narayan P
    Magn Reson Med; 1993 Feb; 29(2):244-8. PubMed ID: 8429789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative analysis of varying profiles of hypoxia in relation to functional vessels in different human glioma xenograft lines.
    Rijken PF; Peters JP; Van der Kogel AJ
    Radiat Res; 2002 Jun; 157(6):626-32. PubMed ID: 12005540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of carbogen breathing on the physiological profile of human glioma xenografts.
    van der Sanden BP; Heerschap A; Hoofd L; Simonetti AW; Nicolay K; van der Toorn A; Colier WN; van der Kogel AJ
    Magn Reson Med; 1999 Sep; 42(3):490-9. PubMed ID: 10467293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 31P NMR spectroscopy measurements of human ovarian carcinoma xenografts: relationship to tumour volume, growth rate, necrotic fraction and differentiation status.
    Rofstad EK; DeMuth P; Sutherland RM
    Radiother Oncol; 1988 Aug; 12(4):315-26. PubMed ID: 3187070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships among lactate concentration, blood flow and histopathologic profiles in rat C6 glioma.
    Terpstra M; High WB; Luo Y; de Graaf RA; Merkle H; Garwood M
    NMR Biomed; 1996 Aug; 9(5):185-94. PubMed ID: 9067999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of hypoxia and hyperoxia on nucleoside triphosphate/inorganic phosphate, pO2 and radiation response in an experimental tumour model.
    Nordsmark M; Maxwell RJ; Horsman MR; Bentzen SM; Overgaard J
    Br J Cancer; 1997; 76(11):1432-9. PubMed ID: 9400939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the neovascular permeability in glioma xenografts by dynamic T(1) MRI with Gadomer-17.
    Verhoye M; van der Sanden BP; Rijken PF; Peters HP; Van der Kogel AJ; Pée G; Vanhoutte G; Heerschap A; Van der Linden A
    Magn Reson Med; 2002 Feb; 47(2):305-13. PubMed ID: 11810674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glioma stem cells involved in tumor tissue remodeling in a xenograft model.
    Dong J; Zhang Q; Huang Q; Chen H; Shen Y; Fei X; Zhang T; Diao Y; Wu Z; Qin Z; Lan Q; Gu X
    J Neurosurg; 2010 Aug; 113(2):249-60. PubMed ID: 20225923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preliminary studies on cell derivation of neovascularization in human glioma and its functional evaluation].
    Fei XF; Zhang QB; Dong J; Wang AD; Wang ZM; Huang Q
    Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):726-31. PubMed ID: 22335902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo nuclear magnetic resonance spectroscopy of a transplanted brain tumour.
    Koeze TH; Lantos PL; Iles RA; Gordon RE
    Br J Cancer; 1984 Mar; 49(3):357-61. PubMed ID: 6704312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor dose response to the vascular disrupting agent, 5,6-dimethylxanthenone-4-acetic acid, using in vivo magnetic resonance spectroscopy.
    McPhail LD; Chung YL; Madhu B; Clark S; Griffiths JR; Kelland LR; Robinson SP
    Clin Cancer Res; 2005 May; 11(10):3705-13. PubMed ID: 15897567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.